soul trial oral semaglutide cardiovascular outcomes soul trial results PDF) and in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the Randomized Post hoc analysis of SUSTAIN

If you would like to learn more, see full prescribing information here

In recent years, the number of prescriptions have exploded due to the weight benefits associated with the class, which has resulted in versions being introduced as diet drugs, which are sold under the brand names Wegovy and Zepbound

The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) have not identified histamine intolerance as a recognised adverse effect of tirzepatide in their product information or pharmacovigilance data

Contextual Cardiovascular Outcomes Trials (CVOTs) Currently, there are no completed head-to-head cardiovascular outcomes trials directly comparing tirzepatide and semaglutide